| Literature DB >> 25242585 |
Hideharu Hagiya1, Susumu Kokeguchi2, Hiroko Ogawa3, Tomohiro Terasaka3, Kosuke Kimura3, Koichi Waseda3, Yoshihisa Hanayama3, Kaori Oda3, Hisatoshi Mori3, Toru Miyoshi4, Fumio Otsuka3.
Abstract
A 53-year-old man with a past medical history of total arch replacement surgery and severe aortic regurgitation presented with a 1-month history of persistent general malaise, anorexia, body weight loss and night sweats. His recent history included gingival hyperplasia for 6 years, gingivitis after tooth extraction 3 years before, prolonged inflammatory status for 4 months, fundal hemorrhage and leg tenderness for 2 months. A pathogen was detected from blood culture, but conventional microbiological examination failed to identify the pathogen. The organism was eventually identified as Cardiobacterium valvarum by 16S rRNA analysis, and the patient was diagnosed with infective endocarditis and prosthetic vascular graft infection. The patient received intravenous antibiotic therapy using a combination of ceftriaxone and levofloxacin for 5 weeks and was discharged with a good clinical course. C. valvarum is a rare human pathogen in clinical settings. Only 10 cases have been reported to date worldwide, and therefore, the clinical characteristics of C. valvarum infection are not fully known. This is a first well-described case of C. valvarum infection in Japan, and further, a first report of aortic prosthetic vascular graft infection worldwide. Identification of C. valvarum is usually difficult due to its phenotypic characteristics, and molecular approaches would be required for both clinicians and microbiologists to facilitate more reliable diagnosis and uncover its clinical picture more clearly.Entities:
Keywords: Aortic vascular graft; Cardiobacterium; Hyperglobulinemia; Infective aneurysm; Infective endocarditis; Septic embolism
Mesh:
Substances:
Year: 2014 PMID: 25242585 DOI: 10.1016/j.jiac.2014.07.008
Source DB: PubMed Journal: J Infect Chemother ISSN: 1341-321X Impact factor: 2.211